Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...

Shares of GSK plc (LON:GSK – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, MarketBeat reports. One research ...

GSK (LON:GSK – Get Free Report)‘s stock had its “underweight” rating reaffirmed by equities research analysts at JPMorgan ...

Bengaluru: Syngene International, a listed subsidiary of Biocon Limited, has announced the appointment of Peter Bains as an ...

Pfizer's complaint is that GSK and a Quebec, Canada-based subsidiary ID Biomedical are causing "commercial uncertainty" for its own RSV vaccine programme with the three patents, which Pfizer says ...

Furthermore, Biocon has scheduled a board meeting on April 4 to discuss and approve fundraising for its commercial business ...

Under a respiratory drug agreement dating back more than a decade, Japan’s Sosei and its UK subsidiary Heptares ... Regulators have started reviews of GSK's depemokimab, aiming to become the ...

GSK Plc and Pfizer Inc. settled a patent-infringement lawsuit over competing vaccines for RSV, ending the dispute in Delaware ...

GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I’d seen in the stock before that. When investing, your capital is at risk ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...